{
  "chapter": "Ans Pharmacology-Anticholinergic Drugs",
  "questions": [
    {
      "q_no": 1,
      "question": "A 34-year-old male presents with symptoms of acute onset blurred vision, dry mouth, tachycardia, and urinary retention. His medical history is unremarkable, and he denies any recent illnesses or medication use. On examination, his pupils are dilated and unreactive to light. Which of the following is the most likely cause of his presentation?",
      "options": {
        "A": "Cocaine toxicity",
        "B": "Opioid overdose",
        "C": "Benzodiazepine intoxication",
        "D": "Atropine poisoning"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Atropine poisoning Explanation: Atropine poisoning (Belladonna poisoning): Atropine is an anticholinergic medication that blocks the action of acetylcholine in the body by binding to muscarinic receptors. In cases of overdose or poisoning, it can cause dry mouth, blurred vision, tachycardia, urinary retention, and dilated pupils, among others. It is treated with physostigmine, which increases ACh levels; it can even cross the blood-brain barrier (BBB) to reverse the CNS effects of atropine poisoning. Cocaine toxicity (Option A) causes symptoms such as euphoria, agitation, increased heart rate, elevated blood pressure, dilated pupils, and potentially seizures or cardiac arrhythmias. It typically presents with signs of sympathetic nervous system stimulation, such as tachycardia and hypertension, rather than the anticholinergic symptoms seen in atropine poisoning. Opioids are a class of drugs that target opioid receptors in the brain and spinal cord to alleviate pain and induce feelings of euphoria. In an overdose, it produces symptoms of CNS depression. (Option B) Benzodiazepines are commonly used in treating anxiety, insomnia, and certain seizure disorders. In cases of intoxication, benzodiazepines can cause sedation, drowsiness, confusion, impaired coordination, and respiratory depression. ( Option C) Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 218",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 2,
      "question": "A 30-year-old woman presents with nausea, dizziness, and vomiting after travelling by boat during a recent vacation. She reports these symptoms occur whenever she is in motion, particularly when sailing or driving on winding roads. The patient states that her symptoms significantly interfere with her ability to enjoy travel and have become increasingly bothersome over time. She is prescribed a patch for her condition. Which is the drug of choice?",
      "options": {
        "A": "Hyoscine",
        "B": "Acetazolamide",
        "C": "Meclizine",
        "D": "Diphenhydramine"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Hyoscine Explanation: The patient's symptoms suggest she is experiencing motion sickness, characterized by nausea, dizziness, and vomiting triggered by motion, such as sailing or driving on winding roads. The drug of choice for her condition is Hyoscine. Hyoscine is the most effective drug used against motion sickness. It is an antimuscarinic that inhibits signal to vestibular nuclei, decreasing motion sickness. It is also the first choice because it is less sedating than other anti-motion sickness drugs like antihistamines. It can be taken orally or as a transdermal patch applied to the mastoid at least 4 hours before travel. Effects can last for 72 hours. Dicyclomine is another anticholinergic that can be used for motion sickness. Meclizine, diphenhydramine, cinnarazine, and promethazine are all antihistamines that treat motion sickness. They are not as effective hyoscine. (Options A, B, and C ruled out) Ephedrine may be added to the anti-motion sickness regimen to counteract sedative properties. Acetazolamide, a carbonic anhydrase inhibitor, is used as the DOC for prophylaxis of acute mountain sickness. (Option D) Reference: https://www.ncbi.nlm.nih.gov/books/NBK539706/ https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575651/ https://pubmed.ncbi.nlm.nih.gov/18626140/",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 3,
      "question": "Which of the following statements is false?",
      "options": {
        "A": "Atropine causes delirium",
        "B": "Hyoscine is used as a truth serum",
        "C": "Hyoscine does not cause sedation",
        "D": "Atropine is used to treat AV node block"
      },
      "correct_answer": "C",
      "explanation": "especially when used in therapeutic doses. It crosses the blood–brain barrier more readily than atropine and causes CNS depression , including drowsiness, amnesia, and fatigue . It has historically been used as a \"truth serum\" due to its CNS depressant and disinhibitory properties. Therefore, the statement \"Hyoscine does not cause sedation\" is false – it does cause sedation. Antimuscarinic Drugs: Effects and Uses Drug CNS Penetration CNS Effects Clinical Uses Atropine Moderate High doses → delirium , hallucinations Bradycardia, AV block, organophosphate poisoning Hyoscine High Sedation, amnesia, motion sickness Motion sickness, pre-anesthetic, “truth serum” Glycopyrrolate Low Minimal CNS effects Used as premedication to reduce secretions without sedation Atropine causes delirium (Option A): Correct – In high doses , atropine crosses the BBB and causes central anticholinergic syndrome , which includes delirium, restlessness, and hallucinations . Hyoscine is used as a truth serum (Option B): Correct – Hyoscine has been historically used in interrogative settings because of its disinhibition and sedative effects . Atropine is used to treat AV node block (Option D): Correct – Atropine blocks parasympathetic tone on the heart, especially the SA and AV nodes , making it first-line for acute AV block or symptomatic bradycardia . Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 214 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9478010/ https://www.sciencedirect.com/topics/neuroscience/scopol amine#:~:text=At%20therapeutic%20doses%2C%20scopolamine%20usually,in%20this%20respect%20than%20sc opolamine .",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 4,
      "question": "A 65-year-old woman with schizophrenia, treated with haloperidol, develops worsening tremors and stiffness. She exhibits bradykinesia, rigidity, and resting tremor, suggestive of parkinsonism. To manage these symptoms, she is prescribed an anticholinergic. Which of the following is not typically an anticholinergic drug but still used for this purpose?",
      "options": {
        "A": "Benzhexol",
        "B": "Benztropine",
        "C": "Bipyridine",
        "D": "Promethazine"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Promethazine Explanation: Drug-induced parkinsonism can result from medications blocking D2 receptors in the basal ganglia (Eg. Haloperidol, Risperidone, Olanzapine, Metoclopramide, Cinnarizine). In the treatment of drug-induced parkinsonism, levodopa is not suitable. Instead, reducing acetylcholine action with anticholinergic and antihistaminic drugs is preferred. Promethazine and diphenhydramine are first-generation antihistamines that act on the basal ganglia and have anticholinergic properties. However, they are still classified as antihistamine agents. They are used for their antiemetic and anti-motion sickness properties. (Option D) Benzhexol (trihexyphenidyl), benztropine, and bipyridine are anticholinergic agents acting on the basal ganglia used to treat Parkinson’s and drug-induced extrapyramidal symptoms. (Options A, B, and C ruled out) Reference: https://www.sciencedirect.com/topics/medicine-and-dentistry/benzatropine#:~:text=Benzatropine%20pa rtially%20blocks%20cholinergic%20activity,of%20Parkinson's%20disease%20and%20dystonia . https://www.ncbi.nlm.nih.gov/books/NBK547977/ https://www.ncbi.nlm.nih.gov/books/NBK548257/#:~:text=Biperi den%20(bye%20per'%20i%20den,transmission%20in%20the%20basal%20ganglia",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 5,
      "question": "A 67 Y/o male with a history of COPD and advanced Parkinson’s disease presents with severe sialorrhea, which significantly impacts his quality of life. The patient has tried multiple treatments, including atropine and scopolamine, with limited success. He is started on a trial of glycopyrrolate. Which of the following is true regarding glycopyrrolate?",
      "options": {
        "A": "Glycopyrrolate crosses BBB and worsens Parkinson's disease",
        "B": "It is contraindicated in COPD as it may cause bronchospasm",
        "C": "It primarily acts on peripheral muscarinic receptors",
        "D": "It is short-acting, requiring multiple doses"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) It primarily acts on peripheral muscarinic receptors Explanation: Glycopyrrolate is an anticholinergic drug that does not cross the blood-brain barrier as it is a quaternary amine (Option A ruled out) . This means it has minimal penetration into the central nervous system (CNS), resulting in fewer CNS side effects. It primarily exerts its effects peripherally, targeting receptors in organs like the salivary glands, gastrointestinal tract, and respiratory system (Option C). By selectively acting on peripheral muscarinic receptors, glycopyrrolate can reduce secretions without causing significant CNS effects like sedation or cognitive impairment. This helps in symptom control in patients with COPD (Option B ruled out ) and is useful in procedures such as endotracheal intubation. It is a long-acting agent requiring less number of doses to reach therapeutic effect (Option D ruled out) Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page217, 1099",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 6,
      "question": "A 68-year-old male patient with COPD (GOLD stage 2) comes in for a regular check-up. His current medications include a short-acting beta2-agonist (SABA) as needed. Despite this treatment, he complained of frequent symptoms and two exacerbations in the last year that required oral corticosteroids. His spirometry shows an FEV1 of 60% predicted. Which of the following drugs can be added to help the patient further?",
      "options": {
        "A": "Tiotropium",
        "B": "Atropine",
        "C": "Hyoscine",
        "D": "Trimipramine"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Tiotropium Explanation: This patient with moderate COPD (GOLD stage 2) who is experiencing frequent symptoms and exacerbations despite the use of a short-acting beta agonist (SABA) would benefit from the addition of a long-acting bronchodilator like Tiotropium, a long-acting muscarinic antagonist (LAMA). Anticholinergics are important in the treatment of chronic obstructive pulmonary disease (COPD), but they are less effective in most patients with asthma. Ipratropium, tiotropium, aclidinium, and umeclidinium are quaternary ammonium LAMAs used for their effects on the respiratory tract. They block acetylcholine action on muscarinic receptors, relaxing airways and improving airflow. Drug Dosage frequency Route Ipratropium Four times daily Metered-dose inhaler or nebuliser Aclidinium Twice daily Dry powder inhaler Tiotropium Once-daily Dry powder inhaler (for maintenance therapy of moderate-to-severe disease) Umeclidinium In COPD treatment, muscarinic antagonists are often used with inhaled long-acting β 2 adrenergic receptor agonists. Olodaterol (very long-acting β 2 adrenergic receptor agonist) is combined with tiotropium bromide to treat COPD. Atropine ( Option B) treats bradycardia and OPC poisoning to counteract muscarinic symptoms. Hyoscine (Scopolamine) ( Option C) is the preferred treatment for motion sickness. It is administered as hyoscine hydrobromide via a transdermal patch, which delivers approximately 0.5 mg of scopolamine over 72 hours. Trimipramine ( Option D) is a tricyclic antidepressant with anticholinergic properties, but it is not indicated for COPD management. Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 128,263,216 Essentials of Medical Pharmacology- K.D Tripathi, 8th Edition, Page 128 https://rdcu.be/dJMJC",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 7,
      "question": "A 45-year-old woman presents to the ophthalmology clinic for a routine eye examination. The ophthalmologist performs a detailed fundoscopic examination to assess the retina. To facilitate this, the ophthalmologist administers an eye drop that causes mydriasis. Which of the following medications is most likely used for this purpose?",
      "options": {
        "A": "Atropine",
        "B": "Tropicamide",
        "C": "Pilocarpine",
        "D": "Timolol"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Tropicamide Explanation: Tropicamide is a short-acting anticholinergic drug with a fast onset. While it is a less reliable cycloplegic, it is suitable for refraction testing in adults and as a short-acting mydriatic for fundoscopy. Anticholinergic drugs block the effects of acetylcholine on the pupillary sphincter muscle, causing mydriasis, and the ciliary muscle, thereby paralyzing accommodation (cycloplegia), fixing the lens for far vision and blurring near vision. Anticholinergic Drug Characteristics Therapeutic Uses Atropine (Option A ruled out) Long-lasting mydriasis and cycloplegia (3-5 days); hence not used in adults Used in treating iritis, iridocyclitis, choroiditis, keratitis, and corneal ulcer Helps to decrease intraocular muscles & reduce spasms Homatropine Semi-synthetic atropine derivative, shorter duration than atropine Used in the treatment of uveitis Cyclopentolate Hydrochloride Potent, rapid-acting Used for refractive error testing Used in the treatment of uveitis Preferred cycloplegic in children (may cause transient behavioral changes in children due to systemic absorption) Tropicamide (Option B) Short-acting, fast onset, less reliable cycloplegic Preferred cycloplegic in adults Used as a short-acting mydriatic for fundoscopy Hyoscine Similar cycloplegic action to atropine, more potent mydriatic, long duration but shorter than atropine Useful for relieving pain in iridocyclitis due to ciliary muscle spasm Pilocarpine ( Option C): is a cholinergic agent that causes miosis (constriction of the pupil), not mydriasis. Timolol ( Option D): is used to lower intraocular pressure and is not used for pupil dilation. Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 214, 217 Essentials of Medical Pharmacology- K.D Tripathi, 8th Edition, Page 123, 131",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 8,
      "question": "A 78-year-old female patient with a known diagnosis of Alzheimer's disease presents to the geriatric clinic with complaints of urinary urgency, frequency, and urge incontinence for the past six months. She is currently taking donepezil for Alzheimer's disease. Which of the following medications is most appropriate for managing this patient's urinary symptoms?",
      "options": {
        "A": "Oxybutynin",
        "B": "Trospium",
        "C": "Solifenacin",
        "D": "Mirabegron"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Trospium Explanation: Trospium , an anticholinergic medication, is commonly used to manage overactive bladder (OAB) symptoms in Alzheimer's patients. This medication is particularly suitable for those with Alzheimer's disease and the elderly due to its reduced CNS penetration, which minimizes the risk of cognitive side effects compared to other anticholinergics like oxybutynin. ANS drugs acting on the urinary bladder: i) Parasympathetic Drugs: CHOLINERGIC DRUGS ANTICHOLINERGIC DRUGS Action: Detrusor contraction Action: Block M3 receptors → Detrusor relaxation Bethanechol Neostigmine Non Selective M3 blockers: Trospium Oxybutynin (Option A) Fesoterodine Flavoxate Selective M3 Blockers: Solifenacin (Option C) Darifenacin Tolterodine Uses: Bladder atony (overflow incontinence) Uses: OAB (urge incontinence) Detrusor overactivity Increased bladder capacity Reduced frequency of bladder contractions Suppression of the urge to urinate ii) Sympathetic drugs: Beta 3 agonists Alpha 1 activator Site: Detrusor Action: Relaxation Site: Internal urinary sphincter Action: Sphincter contraction Mirabegron (Option D) Vibegron Duloxetine (SNRI): Increased epinephrine availability → I 1 stimulation Uses: Urge incontinence Uses: Stress incontinence Urethral hypermobility or intrinsic sphincter dysfunction causes leaks with increased intra-abdominal pressure Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 216 Essentials of Medical Pharmacology- K.D Tripathi, 8th Edition, Page 129",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 9,
      "question": "A 36-year-old woman presents with severe cramping abdominal pain and nausea. She reports that the pain started abruptly a few hours ago and is associated with bloating and diarrhea. She has a history of irritable bowel syndrome (IBS), and similar episodes have occurred in the past. Which of the following medications is most appropriate for relieving her symptoms?",
      "options": {
        "A": "Telenzepine",
        "B": "Scopolamine",
        "C": "Hexamethonium",
        "D": "Thiopentone"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Scopolamine Explanation: Scopolamine is an anticholinergic medication with antispasmodic effects, making it suitable for treating abdominal cramping and spasms linked to conditions like irritable bowel syndrome (IBS). Scopolamine, by blocking muscarinic receptors in the GI tract, causes: Reduced Tone and Motility: This slows down the passage of gastrointestinal contents. Antispasmodic Effect: Helps to alleviate spasms and cramps by reducing the tone and contractions of the gastrointestinal tract. Other antispasmodic anticholinergic drugs: Dicyclomine: Used as an antispasmodic for irritable bowel syndrome (IBS) and other gastrointestinal problems. Valethamate: Used to hasten dilation of the cervix during labor and as a visceral antispasmodic for urinary, biliary, and intestinal colic. Telenzepine (Option A) and pirenzepine are selective M1 receptor antagonists used to reduce HCl production in peptic ulcer disease. Hexamethonium (Option C) is a ganglionic blocker that inhibits the transmission of parasympathetic nerve impulses. Thiopentone (Option D) is an ultra-short-acting barbiturate used as a general anesthetic. It is used in the management of refractory status epilepticus and is the drug of choice for narco analysis. Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 215, 217 Essentials of Medical Pharmacology- K.D Tripathi, 8th Edition, Page 124 (image), 129 https://rdcu.be/dJOrj",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 10,
      "question": "A 9-year-old girl is brought to the pediatrician for frequent, forceful eye blinking and throat clearing, especially when anxious or excited. These brief episodes occur multiple times per hour. She was diagnosed and started on a ganglionic blocker to manage tics. Which of the following could be the possible side effects of the drug?",
      "options": {
        "A": "Bradycardia",
        "B": "Urinary incontinence",
        "C": "Increased salivation",
        "D": "Orthostatic hypotension"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) Orthostatic hypotension Explanation: Based on the clinical scenario, the patient likely has Tourette syndrome, characterized by repetitive tics starting in childhood. Mecamylamine, a ganglionic blocker used for managing tics, can cause side effects such as orthostatic hypotension, tachycardia, urinary retention, dry mouth, and constipation. Ganglion blockers inhibit the transmission of nerve impulses through autonomic ganglia and act primarily by blocking nicotinic acetylcholine receptors (nAChRs), which are ligand-gated ion channels found on the surface of ganglion cells. GANGLION BLOCKERS Persistent depolarising blockers Nicotine (Large doses) Anticholinesterases (Large doses) Competitive blockers Trimethaphan: Competes with Ach at NMJ. Analogous to the MOA of curare at the NMJ Used in hypertension related to a dissecting aortic aneurysm, as it helps block the sympathetically mediated increase in ejection velocity, which is beneficial Channel blockers (Blocks Nn receptor after the channel opens, shortening the current flow duration by occluding or closing the channel) Hexamethonium: Used to treat hypertensive emergencies (no longer in use) Mecamylamine: Used in nicotine dependence to reduce withdrawal symptoms and cravings (Used in adjunct with nicotine) Used in Mx of Tourette syndrome As an antihypertensive for moderate to severe HTN Ganglion blockers inhibit both sympathetic and parasympathetic ganglia, affecting organs based on the dominant control of the autonomic nervous system. EFFECTS ON GANGLION BLOCKADE ON ORGAN SYSTEMS Organ System Effect of blockade Blockade of the dominant tone CVS (Option A ruled out) (Option D) Heart: Tachycardia Parasympathetic blockade Blood vessels: Vasodilatation, postural hypotension due to decreased venous return Sympathetic blockade GIT (Option C ruled out) Decreased motility, constipation, and dry mouth Parasympathetic blockade Urinary bladder (Option B ruled out) Urinary retention Parasympathetic blockade Eye Mydriasis (pupil dilation) and cycloplegia (paralysis of accommodation). Parasympathetic blockade Sweat glands Anhydrosis (decreased sweating) Sympathetic blockade Male sexual function Inability to maintain erection Inhibition of ejaculation Sympathetic and Parasympathetic blockade Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 245 Essentials of Medical Pharmacology- K.D Tripathi, 8th Edition, Page 134, 135",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 11,
      "question": "A 43-year-old Man presents with increased mouth secretions, mild respiratory difficulty, and a heart rate of 52 bpm after eating sushi. While being examined, the patient loses consciousness. The patient is given atropine. Which of the following describes the action of atropine on heart rate?",
      "options": {
        "A": "Tachycardia",
        "B": "Initial tachycardia followed by bradycardia",
        "C": "Initial bradycardia followed by tachycardia",
        "D": "Worsens bradycardia"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer: C) Initial bradycardia followed by tachycardia Explanation: Effects of atropine on heart rate: Atropine when administered parenterally causes initial bradycardia followed by tachycardia. (Option A,B and D ruled out) Therefore, stimulation of M1 receptors decreases the release of ACh and results in tachycardia, and inhibition of M1 receptors increases the release of ACh and results in bradycardia. Atropine initially blocks the M1 receptors causing an increase in ACh which in turn causes initial bradycardia. As the atropine concentration increases, it blocks M2 receptors on the SA node which leads to a decrease in ACh causing tachycardia.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Ans_Pharmacology-Anticholinergic_Drugs_Q11_exp.jpg",
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    },
    {
      "q_no": 12,
      "question": "A 67-year-old male patient with a known history of primary open-angle glaucoma presents to the clinic for a routine eye examination. He reports no new symptoms, and his intraocular pressure (IOP) has been well controlled. Which of the following medications is preferred in this patient for dilating the pupils?",
      "options": {
        "A": "Atropine",
        "B": "Phenylephrine",
        "C": "Homatropine",
        "D": "Cyclopentolate"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Phenylephrine Explanation: For the patient mentioned above with a past medical history of open-angle glaucoma, the mydriatic of choice is phenylephrine. Mydriatics and cycloplegics: Drug Indications Ocular side effects Atropine Cycloplegia, mydriasis, iritis, uveitis Photosensitivity, blurred vision, open-angle glaucoma Homatropine Cyclopentolate Cycloplegiaa, mydriasis Photosensitivity, blurred vision, open-angle glaucoma Phenylephrine Mydriasis, vasoconstriction, uveitis, glaucoma Acts for several hours Phenylephrine is an alpha-1 adrenergic agonist, causing pupil dilation without increasing the intraocular pressure (Option B). Anticholinergic drugs such as atropine, homatropine, and cyclopentolate are potent mydriatics and cycloplegics that significantly raise the IOP (Options A, C & D ruled out). Therefore, in patients with Open-angle glaucoma, anticholinergics are contraindicated. Reference: Goodman and Gilman's- The Pharmacological Basis of Therapeutics, 14th Edition, Page 119-20",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Ans Pharmacology-Anticholinergic Drugs"
    }
  ]
}
